First Eagle Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $607M | Buy |
2,517,313
+951,123
| +61% | +$230M | 1.19% | 34 |
|
|
2025
Q1 | $381M | Buy |
1,566,190
+852,685
| +120% | +$208M | 0.8% | 43 |
|
|
2024
Q4 | $234M | Buy |
713,505
+505
| +0.1% | +$166K | 0.52% | 55 |
|
|
2024
Q3 | $239M | Buy |
713,000
+76,725
| +12% | +$25.7M | 0.49% | 54 |
|
|
2024
Q2 | $174M | Buy |
636,275
+634,311
| +32,297% | +$173M | 0.39% | 58 |
|
|
2024
Q1 | $679K | Buy |
1,964
+1,485
| +310% | +$514K | ﹤0.01% | 357 |
|
|
2023
Q4 | $155K | Buy |
479
+21
| +5% | +$6.78K | ﹤0.01% | 393 |
|
|
2023
Q3 | $164K | Buy |
458
+267
| +140% | +$95.7K | ﹤0.01% | 383 |
|
|
2023
Q2 | $72.4K | Buy |
+191
| New | +$72.4K | ﹤0.01% | 381 |
|